QTREX Quantum Ltd. - Ordinary Shares (QTEX)

2.1000
+0.5800 (38.16%)
NASDAQ· Last Trade: May 28th, 3:28 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.520
Open1.260
Bid2.180
Ask2.190
Day's Range1.220 - 2.350
52 Week Range0.2830 - 2.350
Volume79,241,595
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume222,120,704

Chart

News & Press Releases

Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside
IGC Pharma, Inc. (NYSE: IGC) a clinical-stage biotechnology company developing AI-powered Alzheimer’s disease therapies, is gaining investor attention after reporting Q1 2026 financial results and continued progress in its ongoing Phase 2 CALMA clinical trial evaluating IGC-AD1 for agitation associated with Alzheimer’s dementia.
Via AB Newswire · May 26, 2026
Why Is QTREX Quantum Stock Soaring On Tuesday?benzinga.com
QTREX Quantum (NASDAQ: QTEX) stock surges over 75% on Tuesday following advanced collaboration talks with a top-five global quantum computing company.
Via Benzinga · May 26, 2026